2 Xideas Ag Laboratory Corp Of America Holdings Transaction History

2 Xideas Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 16, 2024	BUY	$209.01 - $232.56 $5.14 Million - $5.72 Million	24,608 Added 111.14%	46,749 $10.2 Million
Q1 2024 May 14, 2024	SELL	$209.01 - $232.56 $6.64 Million - $7.39 Million	-31,764 Reduced 58.93%	22,141 $4.84 Million
Q4 2023 Feb 14, 2024	BUY	$197.69 - $227.29 $164,675 - $189,332	833 Added 1.57%	53,905 $12.3 Million
Q3 2023 Nov 07, 2023	BUY	$201.05 - $221.7 $438,289 - $483,306	2,180 Added 4.28%	53,072 $10.7 Million
Q2 2023 Aug 10, 2023	BUY	$211.93 - $241.33 $1.23 Million - $1.4 Million	5,804 Added 12.87%	50,892 $12.3 Million
Q1 2023 May 11, 2023	BUY	$213.32 - $257.83 $213,533 - $258,087	1,001 Added 2.27%	45,088 $10.3 Million
Q4 2022 Feb 14, 2023	BUY	$203.72 - $248.97 $8.98 Million - $11 Million	44,087 New	44,087 $10.4 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of 2 Xideas Ag, based on Form 13F filings with the SEC.

Stay updated on 2 Xideas Ag with notifications on news.